Solara Active Pharma Sciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: SOLARA | BSE: 541540
₹512.75 
-24.30 (-4.52 %)
Last Updated: 04 Apr 2025 03:55 PM
BULLISH
Overview
Open (₹) 538.80
High (₹) 541.30
Low (₹) 510.20
Prev. Close (₹) 537.05
Volume 84,148
VWAP (₹) 464.10
ROCE (%) -17.42
Industry P/E 44.73
TTM P/E -8.17
P/B Ratio 1.97
Market Cap (₹) Cr.2,064.02
Dividend Yield (%)--
EPS (₹) -157.62
ROE-60.59%
Sales Growth (%) -10.73
Profit Growth (%)2,448.13
Day Range
541.30541.30
52 Week Range
366.95885.95
Historical Returns
Returns (6M)
-28.86 %
Returns (1Y)
34.16 %
Returns (3Y)
-25.6 %
Returns (5Y)
12.08 %
Returns (6M)
-28.86 %
Returns (1Y)
34.16 %
Returns (3Y)
-25.6 %
Returns (5Y)
12.08 %
SWOT Analysis
- Company with (2458.77%) TTM EPS Growth
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BULLISHRSI 49.03
MFI 32.91
ATR 28.39
Commodity Channel Index -104.68
ROC125 -32.90
ROC21 -4.81
Williams %R -74.92
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 481.05 | 489.50 | 502.00 | 468.55 | 460.10 | 447.60 | 439.15 |
| Week Ago | 500.00 | 508.90 | 526.40 | 482.50 | 473.60 | 456.10 | 447.20 |
| Month Ago | 543.99 | 584.02 | 604.04 | 523.97 | 483.94 | 463.92 | 423.89 |
EMA & SMA
512.75
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
7
5 Day 484.18
9 Day 485.33
10 Day 482.66
12 Day 491.98
14 Day 495.91
20 Day 502.92
26 Day 517.96
50 Day 595.93
100 Day 684.90
200 Day 641.97
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| TPG GROWTH IV SF PTE LTD | block | Sell | 28 Jun, 2024 | ₹495.00 | 20,00,000 | NSE |
| AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED | block | Buy | 28 Jun, 2024 | ₹495.00 | 20,00,000 | NSE |
| TPG GROWTH IV SF PTE LTD | bulk | Sell | 28 Jun, 2024 | ₹495.00 | 20,00,000 | NSE |
| AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED | bulk | Buy | 28 Jun, 2024 | ₹495.00 | 20,00,000 | NSE |
| QE SECURITIES LLP | bulk | Sell | 22 Apr, 2024 | ₹589.33 | 2,33,364 | NSE |
| MICROCURVES TRADING PRIVATE LIMITED | bulk | Sell | 22 Apr, 2024 | ₹587.92 | 2,24,655 | NSE |
| HRTI PRIVATE LIMITED | bulk | Sell | 22 Apr, 2024 | ₹588.39 | 2,45,326 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 22 Apr, 2024 | ₹585.88 | 2,76,245 | NSE |
| QE SECURITIES LLP | bulk | Buy | 22 Apr, 2024 | ₹588.86 | 2,36,554 | NSE |
| MICROCURVES TRADING PRIVATE LIMITED | bulk | Buy | 22 Apr, 2024 | ₹587.89 | 2,24,655 | NSE |
| HRTI PRIVATE LIMITED | bulk | Buy | 22 Apr, 2024 | ₹587.59 | 2,41,797 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 22 Apr, 2024 | ₹584.81 | 2,76,245 | NSE |
| PRONOMZ VENTURES LLP | block | Sell | 10 May, 2021 | ₹1,552.05 | 8,70,000 | NSE |
| SHIVANAND SHANKAR MANKEKAR (HUF) | block | Buy | 10 May, 2021 | ₹1,552.05 | 8,70,000 | NSE |
| JITESH DEVENDRA | block | Sell | 20 Apr, 2021 | ₹1,462.30 | 2,30,000 | NSE |
| FIRST STATE INVESTMENT | block | Buy | 20 Apr, 2021 | ₹1,462.30 | 2,30,000 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 14 Mar, 2025 | Kausalya Santhanam | Acquisition | ₹500.06 | 1,000 | NSE |
| 06 Mar, 2025 | Pronomz Ventures LLP | Acquisition | ₹461.50 | 13,600 | NSE |
| 04 Mar, 2025 | Pronomz Ventures LLP Revised | Acquisition | ₹474.31 | 2,16,361 | NSE |
| 28 Feb, 2025 | Pronomz Ventures LLP | Acquisition | ₹473.48 | 1,52,156 | NSE |
| 14 Feb, 2025 | Pronomz Ventures LLP | Acquisition | ₹524.82 | 34,000 | NSE |
| 05 Feb, 2025 | Pronomz Ventures LLP | Acquisition | ₹516.68 | 78,000 | NSE |
| 27 Sept, 2024 | Ramakrishnan R | Acquisition | ₹808.30 | 3,000 | NSE |
| 26 Sept, 2024 | Ramakrishnan R | Acquisition | ₹773.25 | 2,000 | NSE |
| 27 Dec, 2023 | Devicam Capital LLP | Disposal | ₹339.65 | 20,13,747 | NSE |
| 08 Dec, 2023 | Karuna Business Solutions LLP | Disposal | ₹335.12 | 35,591 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 05 Jul, 2023 | Rights issue of equity shares of Rs. 10/- in the ratio of 1:3 @ premium of Rs. 365/-. | 15 May, 2024 | 15 May, 2024 |
| 06 May, 2021 | Rs.3.0000 per share(30%)Dividend | 18 Aug, 2021 | 01 Jan, 1970 |
| 06 Nov, 2020 | Rs.4.0000 per share(40%)Interim Dividend | 19 Nov, 2020 | 20 Nov, 2020 |
| 07 May, 2020 | Rs.2.0000 per share(20%)Dividend | 28 Jul, 2020 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 02 Apr, 2025 | BSE India | Outcome: Solara Active Pharma Sciences Limited informed the exchange about the Rights Issue Committee Meeting held today (i.e.) on April 02, 2025 interalia to consider and approve the First call money notice to be sent to the eligible shareholders. |
| 02 Apr, 2025 | BSE India | Solara Active Pharma Sciences Limited informed the exchange about the outcome of the Rights Issue Committee Meeting held today (i.e.) April 02, 2025 interalia to consider and approve the First call money notice to be sent to the eligible shareholders |
| 02 Apr, 2025 | NSE India | Solara Active Pharma Sciences Limited has informed the Exchange regarding Rights Issue Committee Meeting held on April 02, 2025 interalia, to consider and approve the First Call Notice to be sent to the eligible shareholders |
| 01 Apr, 2025 | NSE India | Members of the Exchange are hereby informed that the trading in the partly paid-up equity shares (Series: E1, ISIN: IN9624Z01014) of Solara Active Pharma Sciences Limited shall be suspended w.e.f. April 04, 2025 (i.e., closing hours of trading on April 03, 2025) on account of first call. |
| 26 Mar, 2025 | NSE India | SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 02-Apr-2025 to consider Alteration of form or nature or rights of securities. |
| 26 Mar, 2025 | BSE India | Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/04/2025 ,inter alia, to consider and approve the First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders |
| 26 Mar, 2025 | NSE India | SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Closure of Trading Window |
| 26 Mar, 2025 | NSE India | Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 26 Mar, 2025 | NSE India | Solara Active Pharma Sciences Limited has informed the Exchange that Record date for the purpose of Calls on Securities is 04-Apr-2025. |
| 26 Mar, 2025 | BSE India | Solara Active Pharma Sciences Limited has informed the exchange about the Record date for the purpose of making first call for the shares issued on Rights Basis. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Others | Inter-alia, to consider 1. The First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders . | 27 Mar, 2025 | 02 Apr, 2025 |
| Rights Issue & Others | Inter-alia, to consider 1. Proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, face value of Rs.10/- each issued by the Company on rights basis. 2. Other business matters. | 27 Mar, 2025 | 26 Mar, 2025 |
| Quarterly Results | -- | 17 Jan, 2025 | 24 Jan, 2025 |
| Quarterly Results | -- | 15 Oct, 2024 | 21 Oct, 2024 |
| Quarterly Results | -- | 16 Jul, 2024 | 22 Jul, 2024 |
| Audited Results | -- | 22 May, 2024 | 29 May, 2024 |
| To consider Fund Raising | -- | 08 May, 2024 | 09 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 09 Nov, 2023 | 14 Nov, 2023 |
| Quarterly Results | (Revised) | 09 Aug, 2023 | 14 Aug, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 37.23% | 30.49% | 40.4% | 39.51% | 44.13% |
| Foreign Institutions + | 14.67% | 16.62% | 19.26% | 18.15% | 12.87% |
| Domestic Institutions + | 3.19% | 1.75% | 3.01% | 5.39% | 4.62% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 44.91% | 51.14% | 37.33% | 36.95% | 38.38% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Solara Active Pharma Sciences
Solara Active Pharma Sciences is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1288.92 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2024.
Parent Organisation
Strides Group
Founded
2017
Managing Director
Mr. Poorvank Purohit
NSE Symbol
SOLARA
Solara Active Pharma Sciences Management
| Name | Designation |
|---|---|
| Mr. R Ramakrishnan | Chairman & Ind.Director |
| Mr. Poorvank Purohit | Managing Director & CEO |
| Mr. Mohan Muthunarayanan | COO & Executive Director |
| Mr. Manish Gupta | Non Executive Director |
| Mr. Kartheek Chintalapati Raju | Non Executive Director |
| Mr. Arun Kumar | Non Executive Director |
| Dr. Kausalya Santhanam | Independent Director |
| Mr. Rajiv Vijay Nabar | Independent Director |
| Mr. Rajendra Kumar Srivastava | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Solara Active Pharma Sciences
What is the share price of Solara Active Pharma Sciences?
The share price of Solara Active Pharma Sciences on 04 Apr, 2025 is ₹ 512.75.
What is 52W high and 52W low share price of Solara Active Pharma Sciences?
The highest and lowest 52W share prices of Solara Active Pharma Sciences are ₹ 885.950 and ₹ 366.950
What is the market cap of Solara Active Pharma Sciences?
The market capitalization of Solara Active Pharma Sciences as of 04 Apr, 2025 is ₹ 2,064.02 Crores
What is the P/E ratio of Solara Active Pharma Sciences?
The current P/E ratio of Solara Active Pharma Sciences as of 04 Apr, 2025 is 44.73
What is the PB ratio of Solara Active Pharma Sciences?
The PB ratio of Solara Active Pharma Sciences as of 04 Apr, 2025 is 1.97
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)